Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19
Clinical trial NCT04252274 · UNKNOWN
Trial details
- NCT number
- NCT04252274
- Sponsor
- Shanghai Public Health Clinical Center
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-30
- Primary completion
- 2020-08-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.